Medical treatment of severe hyperparathyroidism and its influence on anaemia in end-stage renal failure.
Argilés
A
A
Centre de Recherche Biochimie Macromoléculaire (CRBM), CNRS LP 9008-INSERM Unit 249, University of Montpellier I, France.
Mourad
G
G
Lorho
R
R
Kerr
P G
PG
Flavier
J L
JL
Canaud
B
B
Mion
C M
CM
D000328:Adult; D000368:Aged; D000740:Anemia / Q000188:drug therapy*; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D006887:Hydroxycholecalciferols / Q000627:therapeutic use; D006961:Hyperparathyroidism / Q000188:drug therapy*; D007676:Kidney Failure, Chronic / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
D006454:Hemoglobins; D006887:Hydroxycholecalciferols; D004921:Erythropoietin; C008088:alfacalcidol